abstract |
The present invention relates to a stem cell composition for intravenous administration containing stem cells at a concentration of 1X 10 7 ‑5×10 8 Cells/ml, in which stem cells have a diameter of 10-20 μm and appear in a single cell state. The stem cell composition of the present invention is suitable for intravenous administration, and after intravascular administration, allows the stem cells to safely reach a target site, thereby exerting their activity in the target tissue. Therefore, the therapeutic effect of the stem cells is greatly increased. |